| 标题 |
[高分]
Outcomes of Child-Pugh B Patients Treated with Single Tremelimumab Regular Interval Durvalumab (Stride) for Unresectable Hepatocellular Carcinoma (uHCC) in a Real-World Cohort 在真实世界队列中接受单次曲美木单抗定期度伐鲁单抗(Stride)治疗不可切除肝细胞癌(uHCC)的Child-Pugh B患者的结局
|
| 网址 | |
| DOI |
10.1159/000533859
doi
|
| 其它 | Bansal S, Amin P, Valerio S, et al. OUTCOMES OF CHILD-PUGH B PATIENTS TREATED WITH SINGLE TREMELIMUMAB REGULAR INTERVAL DURVALUMAB (STRIDE) FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA (UHCC) IN A REAL-WORLD COHORT[C]//HEPATOLOGY. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA: LIPPINCOTT WILLIAMS & WILKINS, 2024, 80: S156-S157. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)